CURRENT REPORT UNDER SECTION 17 OF THE SECURITIES REGULATION CODE AND SRC RULE 17.2(c) THEREUNDER
1. Date of Report (Date of earliest event reported)
Jun 19, 2024
2. SEC Identification Number
148022
3. BIR Tax Identification No.
000-288-655-000
4. Exact name of issuer as specified in its charter
Euro-Med Laboratories Phil., Inc.
5. Province, country or other jurisdiction of incorporation
Metro Manila
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
PPL Building, United Nations Avenue corner San Marcelino St., ManilaPostal Code1007
8. Issuer's telephone number, including area code
00-63-2-85240091 to 98
9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
common shares
4,112,140,540
11. Indicate the item numbers reported herein
Item 9
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
Euro-Med Laboratories Phil., Inc.EURO
PSE Disclosure Form 4-24 - Results of Annual or Special Stockholders' Meeting References: SRC Rule 17 (SEC Form 17-C) and Section 4.4 of the Revised Disclosure Rules
Subject of the Disclosure
Results of the Annual Stockholders’ Meeting
Background/Description of the Disclosure
Euro-Med Laboratories Phil., Inc. (the “Corporation”) held its Annual Stockholders’ Meeting today, 19 June 2024 conducted virtually via http://meeting.euromedlab.net at 10:00 o’clock in the morning. All of the members of the Board of Directors were present at the meeting.
List of elected directors for the ensuing year with their corresponding shareholdings in the Issuer
Name of Person
Shareholdings in the Listed Company
Nature of Indirect Ownership
Direct
Indirect
Dr. William G. Padolina
20,564
0
-
Mr. Edwin D. Feist
11,607
0
-
Mrs. Georgiana S. Evidente
1,285,052
0
-
Evangeline V. Baviera, M.D.
41,645
0
-
Esperanza I, Cabral, M.D.
1,000
0
-
Mr. Anthony Joseph Y. Gaw
586,617
0
-
Dr. Johnny C. Yap
36,980,720
568,393
owns a share from the majority stockholder
Mr. Benjamin C. Yap
1,000
1,767,402
owns a share from the majority stockholder
Mr. Basilio C. Yap
20,564
1,755,190
owns a share from the majority stockholder
Dr. Enrique Y. Yap, Jr.
41,125
738,515
owns a share from the majority stockholder
External auditor
Aquino, Mata, Calica and Associates
List of other material resolutions, transactions and corporate actions approved by the stockholders
The stockholders likewise approved the following :
1. Minutes of the previous Annual Shareholders’ Meeting held on June 21, 2023; 2. Management Report for Fiscal Year 2023; 3. Ratifications, Proceedings and Resolutions of the Board of Directors and Officers of the Corporation from June 21, 2023 up to the date of this year’s Annual Shareholders’ Meeting; and 4. Re-Nomination of Dr. William G. Padolina and Mr. Edwin D. Feist as Independent Directors